None listed
Conditions
Interventions
Intervention1: Abbott Freestyle Libre Pro: Its a continuous glucose monitoring device to be used to analyze diabetes biomarkers
Intervention2: NIL: NIL
Sponsors
Klick Inc
Eligibility
Inclusion criteria
Inclusion criteria: Either male or non-pregnant, non-lactating female aged > 18-60 Subjects willing to give written informed consent Healthy Volunteers. Subjects able to comply with the study protocol Women of child bearing potential must have a negative urine pregnancy test prior to study entry Minimum 4 subjects in each interval of approx 7 years(18-25/26-32/32-38/39-45/46-52/53-59) Minimum 40% subjects of one gender to mark relative distribution.
Exclusion criteria
Exclusion criteria: Any person below the age of 18 years Suspected or confirmed pregnancy Currently breastfeeding Diagnosis of any known chronic or acute medical disease of any kind (e.g., cardiovascular disease, respiratory disease, influenza, pneumonia, etc.) Diagnosis of any known neurological disease or psychological disorder of any kind (e.g., brain lesion, epilepsy, anxiety, eating disorder, mood disorder, sleep disorder, etc.) Any implanted electrical medical device (e.g., pacemaker, insulin pump, deep brain stimulator, etc.) Any form of prescription medication Use of antibiotics in the three months prior to enrollment Any person planning to undergo a Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment during the duration of the study (as per restrictions of the FreeStyle Libre pro device)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Type 2 Diabetes Glucose biomarkers data with continuous blood glucose dataTimepoint: 2 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
India
Contacts
Public ContactMichael Lieberman PhD
Mittal Global Clinical Trial Services
Outcome results
None listed